Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma

J Natl Cancer Inst. 1990 Jun 20;82(12):1071. doi: 10.1093/jnci/82.12.1071-a.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Humans
  • Interferon-gamma / adverse effects*
  • Melanoma / therapy*
  • Neoplasm Staging
  • Recombinant Proteins
  • Skin Neoplasms / therapy*

Substances

  • Recombinant Proteins
  • Interferon-gamma